受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|
化学式 | C21 H18 F3 N3 O3 S2 |
|||
分子量 | 481.51 | CAS No. | 1432660-47-3 | |
Solubility (25°C)* | 体外 | DMSO | 96 mg/mL (199.37 mM) | |
Ethanol | 96 mg/mL (199.37 mM) | |||
Water | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | AGI-6780 is a potent and selective inhibitor of IDH2 R140Q mutant with IC50 of 23 nM. |
---|---|
in vitro | AGI-6780 potently reduce (R)-2-hydroxyglutarate (2HG) levels in cell lines ectopically overexpressing IDH2/R140Q with EC50 of 20 nM, with excellent selectivity against other dehydrogenases. AGI-6780 reverses the IDH2/R140Q-induced differentiation block in TF-1 cells, and induces blast differentiation in primary human IDH2/R140Q AML patient samples. [1] |
キナーゼアッセイ | Enzymatic assay of IDH inhibitors | |
---|---|---|
Compound is prepared as 10 mM stock in DMSO and diluted to 50X final concentration in DMSO, for a 50 μL reaction mixture. IDH enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate is measured using a NADPH depletion assay. In the assay the remaining cofactor is measured at the end of the reaction with the addition of a catalytic excess of diaphorase and resazurin, to generate a fluorescent signal in proportion to the amount of NADPH remaining. IDH enzyme activity in the direction of isocitrate to alpha-ketoglutarate conversion is measured by direct coupling of the NADPH production to conversion of resazurin to resorufin by diaphorase. In both cases, resorufin is measured fluorometrically at Ex544 Em 590. For assay of the IDH2/R140Q homodimer and the IDH2-R140Q/WT heterodimer, protein is diluted to 0.31 μg/ml in 40 μl Assay Buffer (150 mM NaCl, 50 mM 3 potassium phosphate pH 7.5, 10 mM MgCl2, 10% glycerol, 0.05% BSA, 2 mM β-mercapoethanol) containing 5 μM NADPH. 1 μl of 50X compound dilution is added and the mixture and incubated for 16 hours at 25°C. The enzymatic reaction is started with the addition of 10 μl of Assay Buffer containing 8 mM alpha-ketoglutarate and incubated at 25°C for 60 minutes. The reaction is stopped with the addition of Detection Buffer (1X Assay Buffer containing 36 μg/ml diaphorase and 18 μM resazurin), incubated for five minutes at room temperature, and read on a SpectraMax 384 platereader. |
Data from [Data independently produced by , , Blood, 2018, doi: 10.1182/blood-2018-05-850826]
Data from [Data independently produced by , , Theranostics, 2018, 8(15):4050-4061]
Targeting PRMT1 prevents acute and chronic graft-versus-host disease [ Mol Ther, 2023, 10.1016/j.ymthe.2023.09.011] | PubMed: 37735873 |
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer [ EMBO J, 2023, e110620.] | PubMed: 36637036 |
Aberrant metabolite trafficking and fuel sensitivity in human pluripotent stem cell-derived islets [ Cell Rep, 2023, 42(8):112970] | PubMed: 37556323 |
Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism [ Biomedicines, 2023, 11(2)475] | PubMed: 36831011 |
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia [ Cancer Cell, 2022, S1535-6108(22)00312-9] | PubMed: 35868306 |
Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy [ J Hematol Oncol, 2022, 15(1):30] | PubMed: 35313945 |
Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma [ iScience, 2022, 25(10):105182] | PubMed: 36248745 |
Mitofusin2 Promotes β Cell Maturation from Mouse Embryonic Stem Cells via Sirt3/Idh2 Activation [ Stem Cells Int, 2022, 2022:1172795] | PubMed: 35386849 |
Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer [ Oncogene, 2021, 10.1038/s41388-021-01968-2] | PubMed: 34349242 |
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells [ Elsevier, 2021, 10.1016/j.micromeso.2021.111320] | PubMed: N/A |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。